May 25, 2016
9 a.m. – 5 p.m.
William H. Foege Bioengineering Building, N130
The BioEngage Program in the Department of Bioengineering (BioE) at the University of Washington (UW) has been established to promote deeper relations between UW-BioE and relevant biomedical/biotech industries in the region and throughout the world. As part of this program, UW Bioengineering will hold a special symposium on May 25, 2016 to explore imaging technologies that can potentially deliver on the promise of precision cancer treatment.
GOAL: The symposium will explore new and existing imaging technologies helping guide surgeries, drive interventional procedures, and optimize personalized therapeutics. Faculty, post-docs, and students at all levels at UW will join with researchers from industry and selected clinicians to discuss current trends in the field, learn about each other’s research expertise, and promote potential research collaborations, development/translation projects, student projects, internships, and targeted recruiting.
BACKGROUND: With the advent of image-guided procedures and robust molecular imaging tools, biomedical imaging has moved beyond conventional diagnosis to include procedure guidance and personalized treatment delivery. Image guidance has revolutionized surgical oncology, especially in the brain. Similarly, imaged-guided procedures have revolutionized interventional oncology and new procedures are expanding into nearly area of tumor management. At the molecular level, new targeted probes for all modern imaging modalities have been developed over the last decade not only for specific diagnosis, but also to help monitor the effectiveness of targeted molecular/cellular therapies for cancer. Overall, imaging is now an essential tool for both diagnosis and treatment in oncology. The UW-BioE sponsored symposium will explore the latest trends in this expanding field and address what is still needed to provide imaging tools that can translate our knowledge of the molecular basis of disease into procedures delivering on the promise of precision cancer treatment.
FORMAT: This will be a day-long event and will consist mainly of short talks and panel discussions by attendees on current and emerging imaging tools focused on precision medicine in oncology and on the barriers to clinical acceptance of these tools. There will also be plenty of time for discussion during break times and at the reception following the formal sessions. At all break sessions, UW students will have posters describing their work.
LOGISTICS: The symposium will be sponsored by the BioEngage Program on May 25, 2016 at the William H. Foege Building on the University of Washington campus.
To register, visit: http://uwbioengage.wix.com/symposium#!register/c2414